راهبرد شرکت‌های دارویی و ارزش افزوده اقتصادی

نوع مقاله: مقاله پژوهشی

نویسندگان

1 دانشیار حسابداری دانشگاه شیراز و حسابدار رسمی

2 دانشجوی کارشناسی ارشد حسابداری دانشگاه شیراز

3 دانشجوی دکتری حسابداری دانشگاه شهید چمران اهواز

چکیده

مقدمه: جست‌و‌جو برای یافتن شاخصی برتر در ارزشیابی شرکت از ویژگی‌های بارز پژوهش­های مالی عصر حاضر است. بر این اساس، مدیران شرکت‌ها به دنبال استقرار چارچوب اقتصادی جدیدی در شرکت‌های خود برای انعکاس بهتر ارزش و سودآوری هستند. از این‌رو، انتخاب راهبرد بهینه از سوی مدیران منجر به ایجاد مزیت رقابتی پایدار می‌شود. لذا، هدف این پژوهش بررسی رابطه بین راهبرد شرکت‌های دارویی پذیرفته شده در بورس اوراق بهادار تهران با ارزش افزوده اقتصادی است.
روش پژوهش: این پژوهش کاربردی و طرح آن از نوع شبه‌تجربی با استفاده از رویکرد پس‌رویدادی است. نمونه پژوهش شامل 190 مشاهده سال-شرکت در بازه زمانی 1392-1383 است. داده‌های پژوهش با بکارگیری نرم‌افزار Eviews نسخه 8 و با استفاده از روش رگرسیون حداقل مربعات معمولی آزمون شد.
یافته‌ها: یافته­های پژوهش حاکی از آن است که بین راهبرد رهبری هزینه و ارزش افزوده اقتصادی رابطه مستقیم و معناداری وجود دارد اما بین راهبرد تمایز و ارزش افزوده اقتصادی رابطه معناداری وجود ندارد.  
نتیجه‌گیری: نتایج پژوهش بیانگر آن است که راهبرد رهبری هزینه تأثیر بسزایی بر بهبود ارزش افزوده اقتصادی شرکت‌های دارویی پذیرفته شده در بورس اوراق بهادار تهران دارد. به سخنی دیگر، مدیران شرکت‌های دارویی درصدد افزایش فروش به وسیله کاهش هزینه‌های تولید هستند.

کلیدواژه‌ها


عنوان مقاله [English]

The Strategy of Pharmaceutical Companies and the Economic Value Added

نویسندگان [English]

  • M. Setayesh 1
  • A. Dehghani Saadi 2
  • M. Salehiniya 3
  • Z. Karami 2
1 Associate Professor, Department of Accounting, Shiraz University, and Certified Public Accountant
2 M. A. Student in Accounting, Shiraz University
3 Ph. D. Student in Accounting, Shahid Chamran University of Ahvaz
چکیده [English]

Introduction: Searching for a prevailing index in evaluating companies is one of the prominent features of the financial researches in the present era. Accordingly, the managers of the companies are trying to establish a new economic framework in their companies for both a better reflection of value and profitability. Hence, choosing an optimal strategy by the managers leads to create a sustainable competitive advantage. Therefore, the aim of this study is to investigate the relationship between the strategy of the pharmaceutical companies listed on the Tehran Stock Exchange and the economic value added.
Method: This study is an applied research, and it uses a quasi-experimental design by means of ex-post-facto approach. The sample of the research includes 190 observations of the year-end of the company from 2004 to 2013. The data of the research have been tested by Eviews Software Version 8 and by the ordinary least square regression method.
Results: The results of the research state that there is a direct and significant relationship between cost leading strategy and economic value added. But, there is not a significant relationship between differentiation strategy and economic value added.
Conclusion: The results of the research suggest that the cost leading strategy has a significant effect on the improvement of economic value added of the pharmaceutical companies listed on the Tehran Stock Exchange. In other words, the managers of the pharmaceutical companies intend to increase the sale by reducing the costs of production.

کلیدواژه‌ها [English]

  • Cost Leading Strategy
  • Differentiation Strategy
  • Economic Value Added
1      Mousavi Shiri, S. M.; Vaghfi, S. H.; and M. Ahangari (2013). “Investigating the Long-Term Memory of Total Price Index of the Tehran Stock Exchange (A Case Study: Pharmaceutical Industry)”, Journal ofHealth Accounting, Vol. 2, No. 6, pp. 78-96.  [In Persian]

2      Imankhan, N.; Mokhtaran, M.; and M. Noori-nasab (2009). “Investigating the Competitive Strategies of Top Iranian Exporter Companies in 2007”, Scientific Journal of Management, Vol. 6, No. 16, pp. 69-79. [In Persian]

3      Namazi, M. (2012). Strategic Management Accounting, 1st Edition, Shiraz: The Imam Hassan Research Center of the Integrated and Informative Systems Affiliated with the Defense Ministry. [In Persian]

4      Noravesh, E.; Salehi, F.; and Gh. Karami (2004). “Investigating the Relationship between  Operating Cash Flows, Operating Income, and Economic Value Added with the Wealth Created for Shareholders”, The Iranian Accounting and Auditing Review, Vol. 11, No. 37, pp. 121-146. [In Persian]

5      Asaadi, A.; Zende Del, A.; and A. Kianinezhad (2013). “The Relationship between the Informative Content of the Economic Value Added and the Traditional Criteria with the Market Value Added of  the Companies”, The Iranian Accounting and Auditing Review, Vol. 20, No. 2, pp. 1-18. [In Persian]

6      Lohman, C.; Fortuin, L.; and M. Wouters (2004). “Designing a Performance Measurement System: A Case Study”, European Journal of Operational Research, Vol. 6, No. 3, pp. 267-286.

7      Mahdavi, Gh. and S. M. Hosseini Azanakhari (2008). “What is the Best Criterion for the Evaluation of the Financial Performance?”, Journal of Economic Research, Vol. 8, No. 4, pp. 121-146. [In Persian]

8      Stewart, G. B. (1991). The Quest for Value: A Guide For Senior Managers, 1st Edition New York: Harper Collin Publisher.

9      Darabi, R. and M. Bani (2009). “Evaluating the Amount of Correlation between Economic Value Added, Net Profit and Operating Income with the Stock Value of Stock Market of the Companies Listed on the Tehran Stock Exchange”, Journal of Finance Accounting, Vol. 1, No.1, pp. 1-18. [In Persian]

10  Mintzberg, H. and J. Lample (2001). “Reflection on the Strategy Process Strategic Thinking for the Next Economy”, Sossey-Bass, Available at: http://sloanreview.mit.edu/ article/refle cting-on-the-strategy-process. [Online] [6 April 2013]

11  Aarabi, S. M. (2006). Strategic PlanningHandbook, 1st Edition, Tehran: Iran Cultural Studies Publications. [In Persian]

12  Parsaian, A. and M. Aarabi (Translator) (2005). Strategic Management, 8th Edition, Tehran: Iran Cultural Studies Publications. [In Persian]

13  Porter, M. E. (1980). “Competitive Strategy: Techniques for Analyzing Industries and Competitors”, Available at: http:// www.hbs.edu/faculty/Pages/i tem.aspx?num=195/. [Online][10 July 2014]

14  Tripathy, A (2006). “Strategic Positioning and Firm Performance”, University of Texas at Dallas Ph. D. Dissertation, Available at:https://www. utdallas.edu/dept/graddean/phds/phds0506.htm/. [Online] [11 August 2014]

15  Chang, H.; Fernando, G. D.; and A. Tripathy (2012). “Strategic Positioning and Productivity”, Working Paper, Drexel University, Philadelphia, PA, Available at: http://www.law.northwes tern.edu/research-faculty/searlecenter/ workingpapers/. [Online] [24 November 2013]

16  Mirzaie, H.; Khataie, M.; and Y. Ghanbari (2013). “Investigating the Relationship between Business Risk and Financial Risk with the Performance of the Pharmaceutical Companies Listed on the Tehran Stock Exchange”, Journal of Health Accounting, Vol. 2, No. 4, pp. 77-91. [In Persian]

17  Yahyazadefar, M.; Shams, Sh.; and S. J. Larimi (2010). “The Relationship between Economic Value Added and Profitability Ratios with the Market Value Added of the Companies Listed on the Tehran Stock Exchange”, The Iranian Accounting and Auditing Review, Vol. 17, No. 59, pp. 113-128. [In Persian]

18  Young, S. D. and S. O’Byrne (2001). EVA and Value Based Management: A Practical Guide to Implementation, 1st Edition, New York: McGraw-Hill.

19  Chen, S. and J. L. Dodd (1997). “Economic Value Added: An Empirical Examination of a New Corporate Performance Measure”, Journal of Management, Vol. 9, No. 3, pp. 318-333.

20  Costigan, M. L. and L. M. Lovata (2002). “Empirical Analysis of Adopters of Economic Value Added”, Management Accounting Research, Vol. 13, No. 2, pp. 215-228.

21  Biddle, G. C.; Brown, R.; and J. S. Wallace (1999). “Evidence on EVA”, Journal of Applied Corporate Finance, Vol. 12, No. 2, pp. 69-79.

22  Lehn, K. and A. K. Makhija (1996). “EVA and MVA: As Performance Measures and Signals for Strategic”, Strategy and Leadership, Vol. 24, No. 3, pp. 34-38.

23  Sharma, A. K. (2010). “Economic Value Added-Literature Review and Relevant Issues”, International Journal of Economics and Finance, Vol. 2, No. 2, pp. 200-220.

24  Izadi-nia, N. (2003). “The Evaluation of Commercial Units Using the Models of Economic Value Added, Free Cash Flows, and by Determining the Price Gap and the Stock Value”, Ph. D. Thesis in Accounting, Allameh Tabataba'i University . [In Persian]

25  Balsam, S.; Fernando, G. D.; and A. Tripathy (2011). “The Impact of Firm Strategy On Performance Measures Used in Executive Compensation”, Journal of Business Research, Vol. 64, No. 2, pp. 187-193.

26  Bryan, D.; Fernando, G. D.; and A. Tripathy (2013). “Bankruptcy Risk, Productivity and Firm Strategy”, Review of Accounting and Finance, Vol. 12, No. 4, pp. 309-326.

27  Fingan, M. (1991). ”Extension of the EVA and MVA Applications”, Financial Analysts Journal, Vol. 1, No. 1, pp. 554-556.

28  Kramer, J. K. and J. R. Peters (2001). “An Inter-Industry Analysis of Economic Value Added as A Proxy for Market Value Added”, Journal of Applied Corporate Finance, Vol. 11, No. 1, pp. 41-49.

29  Bowman, C. and V. Ambrosini (2007). “Firm Value Creation and Levels of Strategy”, Management Decision, Vol. 45, No. 3, pp. 360-371.

30  Anastassis, C. and D. Kyriazis (2007). “The Validity of the Economic Value Added Approach: An Empirical Application”, European Financial Management, Vol. 13, No. 1, p. 71-100.

31  Charoendeesawat, S. (2011). “The Explanatory Power of Accounting Measures, EVA and MVA on Stock Returns: Evidence from Thailand Stock Market”, Business Management, Vol. 8, No. 2, pp. 1-49.

32  Bryan, D.; Fernando, G. D.; and A. Tripathy (2013). “Bankruptcy Risk, Productivity and Firm Strategy”, Review of Accounting and Finance, Vol. 12, No. 4, pp. 309-326.

33  Chen, Y. and J. Jermias (2014). “Business Strategy, Executive Compensation and Firm Performance”, Accounting and Finance, Vol. 54, No. 1, pp. 113-134.

34  Banker, R. D.; Mashruwala, R.; and A. Tripathy (2014). “Does A Differentiation Strategy Lead to More Sustainable Financial Performance than A Cost Leadership Strategy?”, Management Decision, Vol. 52, No. 5, pp. 872-896.

35  Anvari Rostami, A.; Tehrani, R.; and H. Seraji (2004). “Investigating the Relationship between Economic Value Added, Earnings before Interest and Taxes, Cash Flow of Operating Activities with the Stock Market Value of the Companies Listed on the Tehran Stock Exchange”, The Iranian Accounting and Auditing Review, Vol. 11, No. 37, pp. 3-21. [In Persian]

36  Mahdavi, Gh. and N. Rastegari (2007). “Informative Content of Economic Value Added in Forecasting Profit”, Journal of Accounting Advances (Journal of Humanities and Social Sciences), Vol. 26, No. 1, pp. 137-156. [In Persian]

37  Mehrani, S. and A. Rasaian (2009). “The Relationship between Economic Value Added and Financial Ratios of the Manufacturing Companies Listed on the Tehran Stock Exchange”, Journal of Economic Research and Policies, Vol. 17, No. 52, pp. 95-116. [In Persian]

38  Valipour, H. and S. Baseri (2010). “The Strategic Position and the Evaluation of Company Performance”, Journal of Management Accounting, Vol. 3, No. 5, pp. 17-29. [In Persian]

39  Honarbakhsh, S.; Birjandi, H.; and M. Birjandi (2012). “Investigating the Relative Effect of the Business Strategy on the Relationship between the Financial Leverage and the Performance of the Companies Listed on the Tehran Stock Exchange”, Journal of Financial Knowledge of Securities Analysis, No. 15, pp. 47-58. [In Persian]

40  Namazi, M. (Translator) (2010). Empirical Research in Accounting: A Methodological Viewpoint, 2nd Edition, Shiraz: Shiraz University Publications. [In Persian]

41  Piri, P.; Heidari, H.; and S. Rauof (2013). “The Relationship between Systematic Risk and Economic Value Added in Iran”, Journal of Economic Research and Policies, No. 66, pp. 169-186. [In Persian]

42  Stewart, G. B. (1995). “EVA Works- But Not if You Make These Common Mistakes”, Journal of Fortune, Vol. 7, No. 2, pp. 117-125.

43  Thomas, A.; Litschert, R.; and K. Ramaswamy (1991). “The Performance Impact of Strategy-Manager Coalignment: An Empirical Examination”, Strategic Management Journal, Vol. 12, No. 7, pp. 509-22.

44  David, J. S.; Hwang, Y.; Pei, B. K.; and W. Reneau (2002). “The Performance Effects of Congruence Between Product Competitive Strategies and Purchasing Management Design”, Management Science, Vol. 48, No. 7, pp. 66-86.

45  Berman, S. L.; Wicks, A. C.; Kotha, S.; and T. M. Jones (1999). “Does Stakeholder Orientation Matter? The Relationship Between Stakeholder Management Models”, Academy of Management Journal, Vol. 42, No. 5, pp. 488-506.

46  Namazi, M. and Sh. Khajavi (2004). “The Usefulness of Accounting Variables in Forecasting the Systematic Risk of the Companies Listed on the Tehran Stock Exchange”, The Iranian Accounting and Auditing Review, Vol. 11, No. 38, pp. 93-119. [In Persian]

47  Badavar-nahandi, Y. and V. Taghizade Khanqah (2014). “Investigating the Relationship between Auditor Tenure and Management of Real Activities in the Pharmaceutical Companies Listed on the Tehran Stock Exchange”, Journal of Health Accounting, Vol. 3, No. 7, pp. 20-41. [In Persian]